Insulet to Present at Upcoming Investor Conferences

Rhea-AI Summary

Insulet Corporation (NASDAQ: PODD), a leader in tubeless insulin pump technology, will present at two investor conferences in March 2022. The first is the Raymond James 43rd Annual Institutional Investors Conference on March 7 at 1:05 PM ET, followed by the Cowen 42nd Annual Health Care Conference on March 8 at 9:50 AM ET. Live webcasts will be available on their website, along with replays post-event. Insulet aims to simplify insulin delivery with its innovative Omnipod system.

ACTON, Mass.--(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod^® brand of products, today announced that management will present at two upcoming investor conferences:

• The Raymond James & Associates 43^rd Annual Institutional Investors Conference on Monday, March 7, 2022, at 1:05 p.m. (Eastern Time)
• The Cowen 42^nd Annual Health Care Conference (Virtual) on Tuesday, March 8, 2022, at 9:50 a.m. (Eastern Time)

To listen to the live webcasts of the presentations, please visit the Company’s website at investors.insulet.com/events. Replays of the webcasts will also be available following the events.

About Insulet Corporation:

Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas. For more information, please visit insulet.com and omnipod.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220222005002/en/

Investor Relations:

Deborah R. Gordon

Vice President, Investor Relations

(978) 600-7717

dgordon@insulet.com

Merrill Robichaud

Investor Relations Coordinator

(978) 932-0444

mrobichaud@insulet.com

Media:

Angela Geryak Wiczek

Senior Director, Corporate Communications

(978) 932-0611

awiczek@insulet.com

Source: Insulet Corporation

FAQ

When will Insulet Corporation present at the Raymond James conference?

Insulet Corporation will present at the Raymond James 43rd Annual Institutional Investors Conference on March 7, 2022, at 1:05 PM ET.

What is the date of Insulet's presentation at the Cowen Health Care Conference?

Insulet Corporation will present at the Cowen 42nd Annual Health Care Conference on March 8, 2022, at 9:50 AM ET.

Where can I watch the Insulet Corporation investor presentations?

You can watch the live webcasts of Insulet's presentations on their website, with replays available afterwards.

What is the focus of Insulet Corporation's Omnipod system?

Insulet Corporation's Omnipod system provides a unique alternative to traditional insulin delivery methods, simplifying life for people with diabetes.

What technology does Insulet Corporation specialize in?

Insulet Corporation specializes in tubeless insulin pump technology, primarily through its Omnipod product line.